glp-1 drugs muscle loss Medications and Lean Loss: What You Need to Know By a Sports and Family Medicine Doctor: Princeton Sports and Family Medicine, P.C.: Sports Medicine Balancing weight and muscle loss

New York: Medscape

Figure 1: Mechanism of Natural GLP-1 in the Joint Environment Source: Created by Haider et al 2026 Discussion Scientists have made a significant breakthrough in arthritis research through their discovery of GLP-1 activity in joint tissues

Moreover, compared with DPP-4 inhibitors and SGLT2 inhibitors, GLP-1RAs significantly reduced hospitalization rates in patients with HF [96]

Additionally, the development of oral formulations, eliminating the need for injections, has broadened the target patient population

GLP-1 receptor agonists available in the UK include: Semaglutide (Ozempic, Wegovy, Rybelsus) - Ozempic and Rybelsus for diabetes, Wegovy for weight management Dulaglutide (Trulicity) Liraglutide (Victoza, Saxenda) - Victoza for diabetes, Saxenda for weight management Lixisenatide (Lyxumia) Exenatide (Byetta, Bydureon) - though usage has declined in recent years These medications are administered either as once-daily, once-weekly, or twice-daily subcutaneous injections, with one oral formulation (semaglutide) also available

Addressing these proactively improves both treatment outcomes and post-treatment maintenance